128 related articles for article (PubMed ID: 8062850)
21. [111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation.
Bakker WH; Albert R; Bruns C; Breeman WA; Hofland LJ; Marbach P; Pless J; Pralet D; Stolz B; Koper JW
Life Sci; 1991; 49(22):1583-91. PubMed ID: 1658515
[TBL] [Abstract][Full Text] [Related]
22. Novel polar single amino acid chelates for technetium-99m tricarbonyl-based radiopharmaceuticals with enhanced renal clearance: application to octreotide.
Maresca KP; Marquis JC; Hillier SM; Lu G; Femia FJ; Zimmerman CN; Eckelman WC; Joyal JL; Babich JW
Bioconjug Chem; 2010 Jun; 21(6):1032-42. PubMed ID: 20402463
[TBL] [Abstract][Full Text] [Related]
23. Receptor scintigraphy with a radioiodinated somatostatin analogue: radiolabeling, purification, biologic activity, and in vivo application in animals.
Bakker WH; Krenning EP; Breeman WA; Koper JW; Kooij PP; Reubi JC; Klijn JG; Visser TJ; Docter R; Lamberts SW
J Nucl Med; 1990 Sep; 31(9):1501-9. PubMed ID: 1975618
[TBL] [Abstract][Full Text] [Related]
24. 99mTc-EDDA/HYNIC-TOC in management of patients with head and neck somatostatin receptor positive tumors.
Trogrlic M; Tezak S
Nucl Med Rev Cent East Eur; 2016; 19(2):74-80. PubMed ID: 27479884
[TBL] [Abstract][Full Text] [Related]
25. Radioiodinated somatostatin analogue RC-160: preparation, biological activity, in vivo application in rats and comparison with [123I-Tyr3]octreotide.
Breeman WA; Hofland LJ; Bakker WH; van der Pluijm M; van Koetsveld PM; de Jong M; Setyono-Han B; Kwekkeboom DJ; Visser TJ; Lamberts SW
Eur J Nucl Med; 1993 Nov; 20(11):1089-94. PubMed ID: 7904561
[TBL] [Abstract][Full Text] [Related]
26. (2-[18F]fluoropropionyl-(D)phe1)-octreotide, a potential radiopharmaceutical for quantitative somatostatin receptor imaging with PET: synthesis, radiolabeling, in vitro validation and biodistribution in mice.
Guhlke S; Wester HJ; Bruns C; Stöcklin G
Nucl Med Biol; 1994 Aug; 21(6):819-25. PubMed ID: 9234331
[TBL] [Abstract][Full Text] [Related]
27. Effects of adding an albumin binder chain on [
Rousseau E; Lau J; Zhang Z; Uribe CF; Kuo HT; Zhang C; Zeisler J; Colpo N; Lin KS; Bénard F
Nucl Med Biol; 2018 Nov; 66():10-17. PubMed ID: 30170196
[TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo evaluation of copper-64-octreotide conjugates.
Anderson CJ; Pajeau TS; Edwards WB; Sherman EL; Rogers BE; Welch MJ
J Nucl Med; 1995 Dec; 36(12):2315-25. PubMed ID: 8523125
[TBL] [Abstract][Full Text] [Related]
29. Evaluation in vitro and in rats of 161Tb-DTPA-octreotide, a somatostatin analogue with potential for intraoperative scanning and radiotherapy.
de Jong M; Breeman WA; Bernard BF; Rolleman EJ; Hofland LJ; Visser TJ; Setyono-Han B; Bakker WH; van der Pluijm ME; Krenning EP
Eur J Nucl Med; 1995 Jul; 22(7):608-16. PubMed ID: 7498221
[TBL] [Abstract][Full Text] [Related]
30. Pre-clinical comparison of [DTPA0] octreotide, [DTPA0,Tyr3] octreotide and [DOTA0,Tyr3] octreotide as carriers for somatostatin receptor-targeted scintigraphy and radionuclide therapy.
De Jong M; Bakker WH; Breeman WA; Bernard BF; Hofland LJ; Visser TJ; Srinivasan A; Schmidt M; Béhé M; Mäcke HR; Krenning EP
Int J Cancer; 1998 Jan; 75(3):406-11. PubMed ID: 9455802
[TBL] [Abstract][Full Text] [Related]
31. Identification and characterization of somatostatin receptors in neonatal rat long bones.
Bruns C; Dietl MM; Palacios JM; Pless J
Biochem J; 1990 Jan; 265(1):39-44. PubMed ID: 1967933
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of a (99m) Tc-labelled meso-bisphenylporphyrin as a tumour image agent.
Santos PM; Laranjo M; Serra AC; Abrantes AM; Piñeiro M; Casalta-Lopes J; Trindade D; Maia J; Rocha-Gonsalves A; Botelho MF
J Labelled Comp Radiopharm; 2014 Mar; 57(3):141-7. PubMed ID: 24634158
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, radiochemistry and biological evaluation of technetium-99m complexes with 1,8-diamine-3,6-dithiaoctane (DDO) ligands.
Maina T; Chiotellis E
Int J Rad Appl Instrum B; 1992 May; 19(4):481-9. PubMed ID: 1526812
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, characterization, conformational analysis of a cyclic conjugated octreotate peptide and biological evaluation of (99m)Tc-HYNIC-His(3)-Octreotate as novel tracer for the imaging of somatostatin receptor-positive tumors.
Behera A; Banerjee I; De K; Munda RN; Chattopadhayay S; Samanta A; Sarkar B; Ganguly S; Misra M
Amino Acids; 2013 Mar; 44(3):933-46. PubMed ID: 23090293
[TBL] [Abstract][Full Text] [Related]
35. An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors.
Gabriel M; Decristoforo C; Donnemiller E; Ulmer H; Watfah Rychlinski C; Mather SJ; Moncayo R
J Nucl Med; 2003 May; 44(5):708-16. PubMed ID: 12732671
[TBL] [Abstract][Full Text] [Related]
36. 99mTc-Demotate 1: first data in tumour patients-results of a pilot/phase I study.
Decristoforo C; Maina T; Nock B; Gabriel M; Cordopatis P; Moncayo R
Eur J Nucl Med Mol Imaging; 2003 Sep; 30(9):1211-9. PubMed ID: 12845487
[TBL] [Abstract][Full Text] [Related]
37. Improved kit formulation for preparation of (99m)Tc-HYNIC-TOC: results of preliminary clinical evaluation in imaging patients with neuroendocrine tumors.
Korde A; Mallia M; Shinto A; Sarma HD; Samuel G; Banerjee S
Cancer Biother Radiopharm; 2014 Nov; 29(9):387-94. PubMed ID: 25379612
[TBL] [Abstract][Full Text] [Related]
38. Analysis of accumulation of 99mTc-octreotide and 99mTc-EDDA/HYNIC-Tyr3-octreotide in the rat kidneys.
Kopecky M; Semecky V; Trejtnar F; Laznicek M; Laznickova A; Nachtigal P; Decristoforo C; Mather SJ; Mäcke HR
Nucl Med Biol; 2004 Feb; 31(2):231-9. PubMed ID: 15013489
[TBL] [Abstract][Full Text] [Related]
39. In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats.
Bakker WH; Krenning EP; Reubi JC; Breeman WA; Setyono-Han B; de Jong M; Kooij PP; Bruns C; van Hagen PM; Marbach P
Life Sci; 1991; 49(22):1593-601. PubMed ID: 1658516
[TBL] [Abstract][Full Text] [Related]
40. Differences in biodistribution between 99mTc-depreotide, 111In-DTPA-octreotide, and 177Lu-DOTA-Tyr3-octreotate in a small cell lung cancer animal model.
Schmitt A; Bernhardt P; Nilsson O; Ahlman H; Kölby L; Forssell-Aronsson E
Cancer Biother Radiopharm; 2005 Apr; 20(2):231-6. PubMed ID: 15869461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
